Pharmacology, An Issue of Anesthesiology Clinics

Alan D. Kaye

2017年6月 · Elsevier Health Sciences

电子书

379

页

符合条件

评分和评价未经验证了解详情

关于此电子书

This issue of Anesthesiology Clinics focuses on Pharmacology. Editor Alan Kaye has assembled an expert team of authors on topics such as: Ketorolac, Oxymorphone and Tapentadol; Anticoagulation and Neuraxial/Peripheral Anesthesia; Pharmacologic Update on Antiemetics: Total parenteral nutrition/enteral nutrition in the ICU, Evolving Concepts; Reversal of Anticoagulants and Anesthesia Considerations; Non-opioids Intravenous or Oral Analgesics for Perioperative Pain Management, Update; Uterotonic Medications and Anesthesia Considerations: oxytocin, misoprostol, methylergonovine, carboprost; Pulmonary Vascular Mediating Drugs, Evolving Concepts; Alpha 2 Modulators and Anesthesia Considerations; Pharmacologic Considerations of Anesthetic Agents in the Obese Patient; Pharmacologic Considerations of Anesthetic Agents in the Geriatric Patient; Pharmacologic Considerations of Anesthetic Agents in the Pediatric Patient; Anesthesia CV Drug Update; Pharmacogenomics: Anesthesia; Pharmacogenomics: Pain; Novel anticoagulants; Novel anesthetic agents; Novel opioids; Pharmacology of Newer Local anesthetics; Pharmacology of Nonsteroidal Antiinflammatory and Steroid Medications. Implications for Anesthesia or Unique Associated Risks; Pharmacology of Octreotide. Implications for Anesthesia and Associated Risks.

作者简介

Dr. Alan David Kaye, MD, PhD, attended the University of Arizona in Tucson for college and medical school. He also completed his PhD in Vascular Pharmacology at Tulane School of Medicine in New Orleans. Dr. Kaye is the Immediate Former Vice Chancellor of Academic Affairs, Chief Academic Officer, Provost, Pain Fellowship Program Director, and Tenured Professor in the Department of Anesthesiology and Pharmacology, Toxicology, and Neurosciences at Louisiana State University Health Sciences Center in Shreveport. He is also the Vice Chairman of Research and Tenured Professor in the Department of Anesthesiology and Pharmacology, Toxicology, and Neurosciences at the Louisiana State University School of Medicine. He served as Program Director and Chairman of anesthesia for 21 years, for 6 years at Texas Tech Health Sciences Center in Lubbock, Texas, and for 15 years at LSU Health Sciences Center in New Orleans, Louisiana, and was a member of the FDA Advisory Committee on Anesthetics, Analgesics, and Addiction Medicine from 2012 to 2020.